Please Wait...

Pulse Wave Analysis

In recent years, emphasis has been placed on the role of arterial stiffness in cardiovascular (CV) disease progression. Arterial stiffness is the major cause of heart attacks, heart failure, and stroke and the assessment of arterial stiffness is increasingly used for assessing CV risk and predicting CV outcomes. In contrast to systemic arterial stiffness, which can only be estimated from models of the circulation, regional and local arterial stiffness can be measured directly and noninvasively between various sites along the arterial tree.

Bioclinica offers a range of non-invasive clinic based and ambulatory central recording methodologies including:

  • Pulse wave analysis
  • Central aortic systolic pressure (CASP)
  • 24-hour central aortic systolic pressure (24-hour CASP)
  • Pulse wave velocity

ADDITIONAL RESOURCES

Collection and Analysis of BP data for Clinical Trials

Download WHITE PAPER

Ambulatory Blood Pressure Monitoring

Download DATA SHEET

Cardiovascular Imaging

Download DATA SHEET

Cardiac Safety Solutions

Download BROCHURE

Global Median Beat (GMB)

Download OVERVIEW SHEET

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

https://t.co/UZQTot9ovJ
bioclinica (18 hours ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica https://t.co/fYGvqU46TI
bioclinica (18 hours ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner https://t.co/MAvm6…
bioclinica (18 hours ago)
RT @eClinical_Jen: Content from the FDA Webinar on Study Data Technical Conformance Guidelines is here: https://t.co/14eepSOR7b #ITTX17
bioclinica (18 hours ago)
RT @CenterWatch: .@US_FDA approves first #digital pill with sensor to track #patients adherence, https://t.co/XaEctKIFRx
bioclinica (18 hours ago)
RT @RAPSorg: Could you use a mid-week laugh? Many #regulatory pros will appreciate this one, courtesy of @CharlesTam https://t.co/8WxeftiCPv
bioclinica (18 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices